acnb - ACNB
ACNB
Close Chg Chg %
52.76 0.01 0.01%
Closed Market
52.77
+0.01 (0.01%)
Volume: 32.45K
Last Updated:
Feb 6, 2026, 4:00 PM EDT
Company Overview: acnb - ACNB
ACNB Key Data
| Open $53.38 | Day Range 52.23 - 53.89 |
| 52 Week Range 35.70 - 53.89 | Market Cap $552.06M |
| Shares Outstanding 10.38M | Public Float 10.02M |
| Beta 0.87 | Rev. Per Employee N/A |
| P/E Ratio 14.66 | EPS $3.56 |
| Yield 261.56% | Dividend $0.38 |
| EX-DIVIDEND DATE Feb 27, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 31.20K |
ACNB Performance
| 1 Week | 4.43% | ||
| 1 Month | 9.17% | ||
| 3 Months | 12.30% | ||
| 1 Year | 28.65% | ||
| 5 Years | 94.69% |
ACNB Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
3
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 56.00 | |
| Number of Ratings | 3 | Current Quarters Estimate | 1.247 | |
| FY Report Date | 03 / 2026 | Current Year's Estimate | 5.117 | |
| Last Quarter’s Earnings | 1.35 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 5.093 | Next Fiscal Year Estimate | 5.143 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 3 | 3 | 3 | 3 |
| Mean Estimate | 1.25 | 1.32 | 5.12 | 5.14 |
| High Estimates | 1.29 | 1.40 | 5.38 | 5.43 |
| Low Estimate | 1.20 | 1.28 | 4.90 | 4.94 |
| Coefficient of Variance | 3.62 | 5.25 | 4.76 | 4.97 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 3 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 1 | 1 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Acnb - ACNB
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Acnb - ACNB
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Dec 18, 2025 | Elizabeth Force Carson Director | 12,721 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 669,633.44 |
| Dec 18, 2025 | Kimberly S. Chaney Director | 9,496 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 499,869.44 |
| Dec 18, 2025 | Eugene J. Draganosky Director | 13,087 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 688,899.68 |
| Dec 18, 2025 | Todd L. Herring Director | 10,287 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 541,507.68 |
| Dec 18, 2025 | Scott L. Kelley Director | 27,579 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 1,451,758.56 |
| Dec 18, 2025 | Donna M. Newell Director | 11,800 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 621,152.00 |
| Dec 18, 2025 | John M. Polli Director | 35,556 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 1,871,667.84 |
| Dec 18, 2025 | Donald Arthur Seibel Director | 6,119 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 322,104.16 |
| Dec 18, 2025 | James J. Lott Director | 18,563 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 977,156.32 |
| Dec 18, 2025 | Brett D. Fulk | 3,306 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $52.27 per share | 172,804.62 |
| Dec 18, 2025 | Alan J. Stock Director | 87,529 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 4,607,526.56 |
| Dec 18, 2025 | Daniel W. Potts Director | 9,755 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 513,503.20 |
| Dec 18, 2025 | Frank Elsner Director | 28,174 | Open market or private purchase of non-derivative security Non-derivative transaction at $52.64 per share | 1,483,079.36 |
| Dec 18, 2025 | Frank Elsner Director | 28,152 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 1,481,921.28 |
| Dec 18, 2025 | Alexandra C. Chiaruttini Director | 2,658 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $52.64 per share | 139,917.12 |
| Mar 21, 2025 | Jason H. Weber EVP, Treasurer & CFO | 9,056 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $41.28 per share | 373,831.68 |
| Mar 21, 2025 | Andrew A Bradley | 1,388 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $41.28 per share | 57,296.64 |
| Mar 21, 2025 | Kevin J. Hayes SVP/Secretary & Gen. Counsel | 3,716 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $41.28 per share | 153,396.48 |
| Mar 21, 2025 | Kevin J. Hayes SVP/Secretary & Gen. Counsel | 3,851 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $41.28 per share | 158,969.28 |
| Mar 21, 2025 | James P. Helt President & CEO; Director | 40,688 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $41.28 per share | 1,679,600.64 |